Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue
M F Pino1, A Divoux1, A V Simmonds2
1Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA.
Background:
Despite successful preclinical testing, 85% of early clinical trials for novel drugs fail. Most futilities originate from molecular mechanisms of the drug(s) tested. It is critically important to develop validated human cell-based model systems in which animal-based research can be translated in order to complement the preclinical in vivo findings prior to implementation of a clinical trial. Obesity is associated with reduced circulating levels of Orexin-A (OX-A) in humans. OX-A increases thermogenesis in rodent brown adipose tissue (AT), yet this phenomenon has not been explored in humans.
Methods:
We established a cell-based model system of human brown and white adipocytes and tested the effects of OX-A on thermogenesis.
Results:
Contrary to published in vivo and in vitro reports in rodents, OX-A treatment alone or in combination with an adrenergic stimulus did neither enhance thermogenesis nor its related transcriptional program in a human in vitro model of brown adipocytes or AT explants.
Conclusions:
Translating preclinical findings in human model systems poses a challenge that must be overcome for the development of effective therapeutic compounds and targets.
Insights
Orexin-A (OX-A) does not increase thermogenesis in human brown adipose tissue, contrary to rodent studies. This highlights challenges in translating preclinical findings to human therapeutic development.
Area of Science:
- Metabolism and Endocrinology
- Cell Biology
- Drug Discovery
Background:
- 85% of early clinical trials fail due to molecular mechanisms, necessitating validated human models.
- Obesity is linked to lower circulating Orexin-A (OX-A) levels in humans.
- Rodent studies show OX-A enhances thermogenesis in brown adipose tissue (AT), but human relevance is unknown.
Purpose of the Study:
- To establish and utilize a human cell-based model system to investigate the effects of OX-A on thermogenesis.
- To determine if OX-A-mediated thermogenesis observed in rodents is conserved in human brown adipocytes.
Main Methods:
- Developed a cell-based model using human brown and white adipocytes.
- Administered OX-A alone and with adrenergic stimuli to the human adipocyte models.
- Assessed thermogenesis and related transcriptional changes.
Main Results:
- Orexin-A treatment did not enhance thermogenesis in human brown adipocytes.
- No increase in thermogenesis or its transcriptional program was observed, even with adrenergic co-stimulation.
- Results contradict previous findings in rodent models.
Conclusions:
- Preclinical findings on Orexin-A's thermogenic effects in rodents do not translate to human brown adipocytes.
- Validated human in vitro models are crucial for overcoming challenges in therapeutic development.
- Further research is needed to understand OX-A's role in human metabolism and identify effective therapeutic targets.
Related Concept Videos
Thermoregulation
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Regulation of Food Intake


